Red I share your sentiment that it has indeed been a long road and I share some of your frustrations also. However, I think it simplistic to suggest that the last 9 years have all been about moving from TST to Quantiferon (well, not directly anyway).
QFT1 was not really a market winner against the TST. QFT2, the gold product was much more competitive but not a great deal of marketing effort was put into it because QFT3, the in-tube product, was already being developed.
QfT gold in-tube has realistically only been on the market for a much shorter period of time, gained FDA approval only in the last 3 years and is only this half being sold in Japan.
In this latter period we have seen exponential profit growth (until the last half, but that had its own issues). I don't know if you understand how significant this exponential profit growth is when we still have such a small market share, but to me it is very significant indeed.
You are right, the next couple of profit results will be very important, but as long as profits continue to grow then I will be happy.
I have full confidence in the marketing efforts to date and the business plan of our management to deliver significant returns on this technology well into the future.
Buying now for growing profits into the future seems a no-brainer to me.
- Forums
- ASX - By Stock
- CST
- qft vs tspot vs tst
qft vs tspot vs tst, page-5
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online